AZD-8848

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAZD-8848
Drug Alias NameAZD-3025DSP-3025AZD-8848
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited KingdomJapan
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca PlcSumitomo Dainippon Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca PlcSumitomo Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsRhinitis, AllergicAsthma

Other Information

ATC CodeN/A
Related LinksN/A